Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Antiplatelet Response
NCT02234427Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in atherosclerosis, sponsored by Johns Hopkins University. Started Jun 2014; status: completed.
02
Drugs
aspirin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02234427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234427.